Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection

Abstract

A 3-month-old male infant was admitted to hospital with anemia. Follow-up controls revealed the presence of specific cytomegalovirus (CMV) antibodies. Virus was isolated from urine, blood, and saliva. At 7 months of age, he presented with melena. Polymerase chain reaction (PCR) of biopsy samples from the duodenum was positive for CMV. Anemia resolved after starting antiviral therapy with oral valganciclovir.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Weinstein M, Ford-Jones E, Cutz E . Esophagitis and perinatal cytomegalovirus infection. Pediatr Infect Dis J 2001; 20: 545–546.

    Article  CAS  Google Scholar 

  2. Schleiss MR . Antiviral therapy of congenital cytomegalovirus infection. Semin Pediatr Infect Dis 2005; 16: 50–59.

    Article  Google Scholar 

  3. Schleiss MR, McVoy MA . Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Exp Rev Anti-infective Ther 2004; 2: 389–403.

    Article  CAS  Google Scholar 

  4. Whitley RJ, Cloud G, Gruber W, Storch GA, Demonler GJ, Jacobs RF et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. J Infect Dis 1997; 175: 1080–1086.

    Article  CAS  Google Scholar 

  5. Kimberlin DW . Antiviral therapy for cytomegalovirus infections in pediatric patients. Semin Pediatr Infect Dis 2002; 13: 22–30.

    Article  Google Scholar 

  6. De Clercq E . Antiviral drugs in current clinical use. J Clin Virol 2004; 30: 115–133.

    Article  CAS  Google Scholar 

  7. Meine Jansen CF, Toet MC, Rademaker CM, Ververs TF, Gerards LJ, van Loon AM . Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir. J Perinat Med 2005; 33: 364–366.

    PubMed  Google Scholar 

  8. Henkin C, Griener J, Ten Eick A . Stability of valganciclovir in extemporaneously compounded liquid formulations. Am J Health-Syst Pharm 2003; 60: 687–690.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Irene Scarano, MD, and Gaetano Mauro, MD, who prepared the oral liquid formulation of valganciclovir.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P S Buonuomo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buonuomo, P., Maurizi, P., Valentini, P. et al. Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection. J Perinatol 26, 648–649 (2006). https://doi.org/10.1038/sj.jp.7211578

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211578

Keywords

This article is cited by

Search

Quick links